Clinical Trial: Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer

U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06910072) titled 'Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer' on Feb. 28.

Brief Summary: This is a prospective, single-arm, multicenter study to observe and evaluate the efficacy and safety of paclitaxel polymeric micelles and carboplatin in combination with iparomilimab and tuvonralimab in neoadjuvant therapy for triple-negative breast cancer. The main endpoint of the study is pCR, 32 patients are scheduled to be enrolled.

Study Start Date: April 02

Study Type: INTERVENTIONAL

Condition: Triple-Negative Breast Cancer (TNBC) Neoadjuvant Thera...